CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,618,000 | -26.8% | 545,973 | -28.1% | 0.00% | -50.0% |
| Q3 2016 | $7,674,000 | -4.0% | 759,002 | +6.6% | 0.00% | 0.0% |
| Q2 2016 | $7,996,000 | -14.8% | 712,064 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $9,385,000 | -26.3% | 687,035 | +2.3% | 0.00% | -33.3% |
| Q4 2015 | $12,735,000 | -5.3% | 671,334 | -6.3% | 0.00% | 0.0% |
| Q3 2015 | $13,447,000 | +31.1% | 716,418 | +4.0% | 0.00% | +50.0% |
| Q2 2015 | $10,259,000 | +171.3% | 688,981 | +176.0% | 0.00% | +100.0% |
| Q1 2015 | $3,781,000 | +21.9% | 249,650 | +7.2% | 0.00% | 0.0% |
| Q4 2014 | $3,102,000 | +1208.9% | 232,904 | +1139.8% | 0.00% | – |
| Q3 2014 | $237,000 | +16.7% | 18,786 | -6.8% | 0.00% | – |
| Q2 2014 | $203,000 | -91.7% | 20,146 | -89.0% | 0.00% | -100.0% |
| Q1 2014 | $2,457,000 | – | 182,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |